Code
MOG-TSTP-03AX
Panel
Active-Compendium
81449
81449
Clinical
Oncology,Pathology
FFPE tissue: Paraffin block is preferred. Alternatively, send 1 H&E slide plus 5-10 unstained slides cut at 5 or more microns. Please use positively-charged slides and 10% NBF fixative. Do not use zinc fixatives.
Flag Active
True
Orderable Test Description
The Targeted Solid Tumor NGS Fusion Panel is an RNA-based next-generation sequencing panel that detects translocations and fusions with known and novel fusion partners of these genes: ALK, BRAF, FGFR1, FGFR2, FGFR3, FGFR4, MET including MET Exon 14 skipping, NOTCH1, NOTCH2, NRG1, NTRK1, NTRK2, NTRK3, PDGFB, PDGFRA, PDGFRB, RAF1, RET, and ROS1.
Orderable Turn Around Time
21 Days
Extra Note
Use cold pack for transport, making sure cold pack is not in direct contact with specimen. NYS clients please provide date and time of Collection.
Orderable Biomarkers
NY Approved
True
Orderable Biomarkers JSON
{"RNA Sequencing": {"Fusions": ["MET", "RAF1", "ROS1", "FGFR4", "NOTCH1", "NOTCH2", "NRG1", "PDGFB", "RET", "FGFR1", "NTRK1", "NTRK2", "NTRK3", "PDGFRA", "PDGFRB", "ALK", "BRAF", "FGFR2", "FGFR3"]}}
Keywords string
solid tumor, gene fusion, gene rearrangement, NGSfusionsearch Targeted Solid Tumor NGS Fusion Panel
Title URL
targeted-solid-tumor-ngs-fusion-panel